Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Soronen, Jarkko ^a,b   Laurila, Pirkka Pekka ^a,b   Naukkarinen, Jussi ^a,b   Surakka, Ida ^a,b   Ripatti, Samuli ^a,b   Jauhiainen, Matti ^a,b   Olkkonen, Vesa M ^d   Yki Järvinen, Hannele ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; MESSENGER RNA; TRIACYLGLYCEROL;

ABDOMINAL FAT ASPIRATION BIOPSY; ABDOMINAL SUBCUTANEOUS FAT; ADULT; ANGPTL4 GENE; ARTICLE; CLINICAL ARTICLE; CYTOKINE RESPONSE; ELOVL6 GENE; FATP2 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; NUCLEOTIDE SEQUENCE; OBESITY; PNPLA3 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SREBF1 GENE; TISSUE MICROARRAY; ADOLESCENT; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRION; SUBCUTANEOUS FAT;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MIDDLE AGED; MITOCHONDRIA; OBESITY; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84859204479     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-9     Document Type: Article

References (58)

1. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Guilherme A, Virbasius JV, Puri V, Czech MP, Nat Rev Mol Cell Biol 2008 9 5 367 377 10.1038/nrm2391 18401346 (Pubitemid 351574198)
2. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Kahn SE, Hull RL, Utzschneider KM, Nature 2006 444 7121 840 846 10.1038/nature05482 17167471 (Pubitemid 46024990)
3. Application of DNA microarrays in the study of human obesity and type 2 diabetes. Sun G, OMICS 2007 11 1 25 40 10.1089/omi.2006.0003 17411394 (Pubitemid 46608892)
4. Obesity-related differential gene expression in the visceral adipose tissue. Baranova A, Collantes R, Gowder SJ, Elariny H, Schlauch K, Younoszai A, King S, Randhawa M, Pusulury S, Alsheddi T, et al. Obes Surg 2005 15 6 758 765 10.1381/0960892054222876 15978142 (Pubitemid 40904861)
5. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, et al. FASEB J 2004 18 14 1657 1669 10.1096/fj.04-2204com 15522911 (Pubitemid 39463705)
6. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C, Sorensen TI, Arner P, Am J Clin Nutr 2005 81 6 1275 1285 15941876 (Pubitemid 41710227)
7. High expression of complement components in omental adipose tissue in obese men. Gabrielsson BG, Johansson JM, Lonn M, Jernas M, Olbers T, Peltonen M, Larsson I, Lonn L, Sjostrom L, Carlsson B, et al. Obes Res 2003 11 6 699 708 10.1038/oby.2003.100 12805391 (Pubitemid 41151596)
8. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Hardy OT, Perugini RA, Nicoloro SM, Gallagher-Dorval K, Puri V, Straubhaar J, Czech MP, Surg Obes Relat Dis
9. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-Millo M, Poitou C, Basdevant A, Stich V, Viguerie N, et al. Genome Biol 2008 9 1 14 10.1186/gb-2008-9-1-r14 18208606 (Pubitemid 351911933)
10. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA, Diabetologia 2005 48 9 1776 1783 10.1007/s00125-005-1867-3 16059715 (Pubitemid 41317831)
11. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Marrades MP, Milagro FI, Martinez JA, Moreno-Aliaga MJ, Biochem Biophys Res Commun 2006 339 3 785 789 10.1016/j.bbrc.2005.11.080 16325777 (Pubitemid 41772882)
12. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. Pietilainen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keranen H, Suomalainen A, Gotz A, Suortti T, Yki-Jarvinen H, et al. PLoS Med 2008 5 3 51 10.1371/journal.pmed.0050051 18336063 (Pubitemid 351471696)
13. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, Hudson TJ, Tchernof A, Obes Res 2004 12 8 1217 1222 10.1038/oby.2004.153 15340102 (Pubitemid 41137463)
14. Evidence of impaired adipogenesis in insulin resistance. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, Cam MC, Cushman SW, Smith U, Biochem Biophys Res Commun 2004 317 4 1045 1051 10.1016/j.bbrc.2004.03.152 15094374 (Pubitemid 38496415)
15. Nutrient sensing and inflammation in metabolic diseases. Hotamisligil GS, Erbay E, Nat Rev Immunol 2008 8 12 923 934 10.1038/nri2449 19029988
16. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Dahlman I, Forsgren M, Sjogren A, Nordstrom EA, Kaaman M, Naslund E, Attersand A, Arner P, Diabetes 2006 55 6 1792 1799 10.2337/db05-1421 16731844 (Pubitemid 44324134)
17. Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Westerbacka J, Corner A, Kannisto K, Kolak M, Makkonen J, Korsheninnikova E, Nyman T, Hamsten A, Fisher RM, Yki-Jarvinen H, Diabetologia 2006 49 1 132 140 10.1007/s00125-005-0075-5 16362280 (Pubitemid 43151624)
18. Insulin regulation of MCP-1 in human adipose tissue of obese and lean women. Westerbacka J, Corner A, Kolak M, Makkonen J, Turpeinen U, Hamsten A, Fisher RM, Yki-Jarvinen H, Am J Physiol Endocrinol Metab 2008 294 5 841 E845 10.1152/ajpendo.00653.2006 18270300
19. Glucose clamp technique: a method for quantifying insulin secretion and resistance. DeFronzo RA, Tobin JD, Andres R, Am J Physiol 1979 237 3 214 E223 382871
20. Assay of glucose transport in human fat cells obtained by needle biopsy. Yki-Jarvinen H, Nikkila EA, Kubo K, Foley JE, Diabetologia 1986 29 5 287 290 10.1007/BF00452064 3522327 (Pubitemid 16080924)
21. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Benjamini Y, Hochberg Y, J Roy Statistical Society B 1995 57 289 300
22. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F, Genome Biol 2002 3 7 ESEARCH0034 12184808
23. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S, J Biol Chem 2006 281 2 934 944 16272564
24. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Saemann MD, Geyeregger R, Schlederer M, Kenner L, et al. Diabetes 59 4 935 946
25. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Zhang J, Wright W, Bernlohr DA, Cushman SW, Chen X, Am J Physiol Endocrinol Metab 2007 292 5 1433 E1440 10.1152/ajpendo.00664. 2006 17244723 (Pubitemid 46684613)
26. Obesity is associated with macrophage accumulation in adipose tissue. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr, J Clin Invest 2003 112 12 1796 1808 14679176 (Pubitemid 38063703)
27. TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K. Gountopoulou A, Leondaritis G, Galanopoulou D, Mavri-Vavayanni M, Cytokine 2008 41 2 174 181 10.1016/j.cyto.2007.11.008 18180165
28. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, Permana PA, Diabetologia 2005 48 9 1784 1788 10.1007/s00125-005-1868-2 16034612 (Pubitemid 41317832)
29. G(s)alpha repression of adipogenesis via Syk. Wang H, Malbon CC, J Biol Chem 1999 274 45 32159 32166 10.1074/jbc.274.45.32159 10542252 (Pubitemid 29522956)
30. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS, J Lipid Res 2005 46 11 2347 2355 10.1194/jlr.M500294-JLR200 16150820 (Pubitemid 41532523)
31. Identification and characterization of small compound inhibitors of human FATP2. Sandoval A, Chokshi A, Jesch ED, Black PN, Dirusso CC, Biochem Pharmacol 79 7 990 999
32. A family of fatty acid transporters conserved from mycobacterium to man. Hirsch D, Stahl A, Lodish HF, Proc Natl Acad Sci USA 1998 95 15 8625 8629 10.1073/pnas.95.15.8625 9671728 (Pubitemid 28350538)
33. Slc27a2 expression in peripheral blood mononuclear cells as a molecular marker for overweight development. Caimari A, Oliver P, Rodenburg W, Keijer J, Palou A, Int J Obes (Lond) 34 5 831 839
34. Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. Matsuzaka T, Shimano H, Yahagi N, Yoshikawa T, Amemiya-Kudo M, Hasty AH, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, et al. J Lipid Res 2002 43 6 911 920 12032166 (Pubitemid 34602613)
35. Mouse Elovl-6 promoter is an SREBP target. Kumadaki S, Matsuzaka T, Kato T, Yahagi N, Yamamoto T, Okada S, Kobayashi K, Takahashi A, Yatoh S, Suzuki H, et al. Biochem Biophys Res Commun 2008 368 2 261 266 10.1016/j.bbrc.2008.01.075 18226595
36. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N, et al. Nat Med 2007 13 10 1193 1202 10.1038/nm1662 17906635 (Pubitemid 47530641)
37. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Romeo S, Huang-Doran I, Baroni MG, Kotronen A, Curr Opin Lipidol 21 3 247 252
38. Adiponutrin: A new gene regulated by energy balance in human adipose tissue. Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, Hainque B, Basdevant A, Langin D, Pairault J, Clement K, J Clin Endocrinol Metab 2004 89 6 2684 2689 10.1210/jc.2003-031978 15181042 (Pubitemid 38766350)
39. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Moldes M, Beauregard G, Faraj M, Peretti N, Ducluzeau PH, Laville M, Rabasa-Lhoret R, Vidal H, Clement K, Eur J Endocrinol 2006 155 3 461 468 10.1530/eje.1.02229 16914601 (Pubitemid 44463953)
40. Variation in the adiponutrin gene influences its expression and associates with obesity. Johansson LE, Hoffstedt J, Parikh H, Carlsson E, Wabitsch M, Bondeson AG, Hedenbro J, Tornqvist H, Groop L, Ridderstrale M, Diabetes 2006 55 3 826 833 10.2337/diabetes.55.03.06.db05-1075 16505250 (Pubitemid 43343243)
41. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. Nat Genet 2003 34 3 267 273 10.1038/ng1180 12808457 (Pubitemid 36792858)
42. Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Mustelin L, Pietilainen KH, Rissanen A, Sovijarvi AR, Piirila P, Naukkarinen J, Peltonen L, Kaprio J, Yki-Jarvinen H, Am J Physiol Endocrinol Metab 2008 295 1 148 E154 10.1152/ajpendo.00580.2007 18460597
43. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Jiang Y, An Y, Shuai Y, et al. Lancet 2008 371 9626 1783 1789 10.1016/S0140-6736(08)60766-7 18502303 (Pubitemid 351697954)
44. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, et al. Lancet 2006 368 9548 1673 1679 10.1016/S0140-6736(06)69701-8 17098085 (Pubitemid 46048554)
45. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models. Voshol PJ, Rensen PC, van Dijk KW, Romijn JA, Havekes LM, Biochim Biophys Acta 2009
46. Insulin downregulates angiopoietin-like protein 4 mRNA in 3 T3-L1 adipocytes. Yamada T, Ozaki N, Kato Y, Miura Y, Oiso Y, Biochem Biophys Res Commun 2006 347 4 1138 1144 10.1016/j.bbrc.2006.07.032 16870142 (Pubitemid 44118232)
47. A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Okubo M, Horinishi A, Saito M, Ebara T, Endo Y, Kaku K, Murase T, Eto M, Mol Genet Metab 2007 92 3 229 233 10.1016/j.ymgme.2007.06.018 17706445 (Pubitemid 47513561)
48. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW, et al. Proc Natl Acad Sci USA 2005 102 17 6086 6091 10.1073/pnas.0408452102 15837923 (Pubitemid 40594259)
49. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin Y, Soukas A, Friedman JM, Holmes WE, Spiegelman BM, Mol Cell Biol 2000 20 14 5343 5349 10.1128/MCB.20.14.5343- 5349.2000 10866690 (Pubitemid 30431587)
50. Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Yu BL, Zhao SP, Hu JR, Obes Rev 2009
51. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target. Le Lay S, Lefrere I, Trautwein C, Dugail I, Krief S, J Biol Chem 2002 277 38 35625 35634 10.1074/jbc.M203913200 12048207
52. Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3 T3 L1 adipocytes. Nadeau KJ, Leitner JW, Gurerich I, Draznin B, J Biol Chem 2004 279 33 34380 34387 10.1074/jbc. M403596200 15187085 (Pubitemid 39318063)
53. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ, Genes Dev 2000 14 22 2819 2830 10.1101/gad.844900 11090130
54. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL, J Clin Invest 1996 98 7 1575 1584 10.1172/JCI118951 8833906 (Pubitemid 26327867)
55. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, et al. J Biol Chem 2002 277 22 19353 19357 10.1074/jbc.M201584200 11923308 (Pubitemid 34967441)
56. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, Riou JP, Vidal H, Diabetes 2001 50 5 1134 1142 10.2337/diabetes.50.5.1134 11334418 (Pubitemid 32374545)
57. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Sewter C, Berger D, Considine RV, Medina G, Rochford J, Ciaraldi T, Henry R, Dohm L, Flier JS, O'Rahilly S, et al. Diabetes 2002 51 4 1035 1041 10.2337/diabetes.51.4.1035 11916923 (Pubitemid 34438347)
58. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Kim JB, Spiegelman BM, Genes Dev 1996 10 9 1096 1107 10.1101/gad.10.9.1096 8654925 (Pubitemid 26152851)